Tumor segmentation software receives 510k clearance from FDA

(Columbia University Medical Center) Columbia University's imaging software that facilitates 3-D lung tumor segmentation, licensed to Varian Medical Systems, has been incorporated into the Smart Segmentation module of Varian's Eclipse treatment planning system and has received Food and Drug Administration 510k clearance.